Pharma, Biotech and Generics Industry News | The Pharmaletter
Jan 2, 2025 · In some good news for the US vaccines developer, whose stock has fallen 66% in the past 12 months, Moderna on Friday announced ongoing support from the US Department …
Pharma USA 2025 - The Pharmaletter
The two day event offers a variety of means for networking and collaboration: Hackathons offering a hyper-interactive session where attendees work as a team to hack strategic issues.
US FDA warning over counterfeit drugs bought in Mexico
May 15, 2005 · The US Food and Drug Administration is warning the public about the sale of counterfeit versions of Pfizer's Lipitor (atorvastatin) and Viagra (sildenafil), and an unapproved …
Citryll raises 85 million euros | The Pharmaletter
Dec 9, 2024 · Dutch biotech Citryll, which is focused on treating immune-mediated inflammatory diseases by targeting neutrophil extracellular traps (NETs), today announced the successful …
Autolus Therapeutics announces FDA approval of Aucatzyl
Nov 11, 2024 · On November 8, the US Food and Drug Administration approved Aucatzyl (obecabtagene autoleucel; obe-cel) from US biopharma Autolus Therapeutics, whose share …
J&J reports strong data for Tecvayli at ASH 2024
Dec 9, 2024 · Johnson & Johnson announces positive Phase II results for Tecvayli in newly diagnosed multiple myeloma, with all patients achieving minimal residual disease negativity. …
Orexo resolves Zubsolv US patent dispute with Sun Pharma
Dec 16, 2024 · Shares of Swedish pharma firm Orexo leapt 20.2% to 20.60 kronor this morning, following its announcement over the weekend that is has reached a settlement agreement with …
Viatris faces FDA import restrictions at Indian facility
Dec 24, 2024 · Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 products while exempting four for shortages. The company …
2024: Emergent trends in pharma and biotech
Dec 30, 2024 · The life sciences industry experienced volatility in 2024, marked by pipeline growth, biologics breakthroughs, and evolving GLP-1 therapies. Challenges in trials, …
Pfizer unveils new China strategy with $1 billion investment
Nov 8, 2024 · Pfizer plans to invest $1 billion in China by 2030 to support innovation, diagnostics, and the biotech sector, aligning with China’s “Healthy China 2030” initiative. This includes an …